Last week there were only three initial public offerings (IPOs) on the calendar. None of the three actually made it out the door, though. One, KineMed, has been postponed and may be withdrawn. This week we have two holdovers from last week plus nine additions to the IPO hopefuls’ list.

To repeat last week’s summary, the year to date has been a massive success for IPOs. According to Renaissance Capital, 148 IPOs have priced in the United States so far this year, up nearly 61% from a year ago. Total proceeds raised come to $31.5 billion, up more than 52% from 2013. In the month of June, IPO proceeds totaled $8 billion, tied with April for the highest monthly total so far this year. The 2013 IPO total came in at $54.9 billion, the highest total in the past 10years. So far in 2014 IPOs have put $31.5 billion into the coffers of new publicly traded companies.

The largest IPO on this week’s calendar is TerraForm Power Inc., another spin-off from SunEdison Inc. (NYSE: SUNE). TerraForm is being created to own and operate clean energy power generation assets it will acquire from SunEdison and other companies as a so-called yieldco. TerraForm’s IPO follows by about a month the IPO of Abengoa Yield PLC (NASDAQ: ABY), which priced above its range and closed its opening day of trading up about 28%.

The company plans to offer 20.1 million shares in an expected price range of $19 to $21. At the mid-point of the range proceeds will total $400.1 million and TerraForm’s market value would be around $2 billion. SunEdison will retain nearly 95% of the voting power in the company, which is expected to price shares on Thursday and begin trading Friday on the Nasdaq under the ticker symbol TERP.

Here is a brief look at the other IPOs due in the coming week.

CareDX Inc. is a commercial stage diagnostics company that offers a product for heart transplant patients. The company plans to offer 6.3 million shares in an expected price range of $11 to $13. Shares are expected to price on Thursday and begin trading Friday on the Nasdaq under the ticker symbol GLOB.

ALSO READ: America’s Most Profitable Products

Globant S.A. offers outsourced IT work to businesses that need assistance with cloud, mobile and big data applications. Globant is domiciled in Luxembourg but is based in Argentina. The company plans to offer 3.1 million shares in an expected price range of $15 to $17. Shares are expected to price on Thursday and begin trading Friday on the New York Stock Exchange (NYSE) under the ticker symbol CDNA.

iRadimed Corp. develops, manufactures and sells MRI-compatible products and claims to be the global leader in sales of non-magnetic IV infusion pump systems. The company plans to sell 1.8 million shares in a price range of $5 to $6. No specific dates are listed for pricing or the start of trading. The shares will trade on the Nasdaq under the ticker symbol IRMD.

Medical Transcription Billing Corp. is held over from last week. The company provides a suite of integrated Web-based solutions and business services (Software as a Service, or SaaS) to health care providers practicing in ambulatory settings. The company is based in New Jersey and its operations are located in Pakistan. The company plans to offer 3 million shares in an estimated price range of $9 to $11. At the midpoint of the price range, the company would raise $30 million. Shares are expected to price Monday and begin trading Tuesday on the Nasdaq under the ticker symbol MTBC.

Microlin Bio Inc. is a development stage diagnostics and therapeutic company that expects to offer 5.5 million units in a price range of $4.50 to $5.50. On July 3, the company changed its offering to create a unit comprising one share and one warrant to purchase a share at a price of $6 within five years. This IPO has been postponed in each of the past four weeks. Pricing and trading dates are once again expected this coming week, but no firm dates have been given. The stock will trade on the Nasdaq under the ticker symbol MCLB.

Pfenex Inc. is a clinical stage biotech firm that is developing a biosimilar product to compete with Lucentis for the treatment of age-related macular degeneration. The company was spun off Dow Chemical Co. (NYSE: DOW) in 2009 and plans to sell 5 million shares in an expected price range of $12 to $14. Shares are expected to price on Thursday and begin trading Friday on the New York Stock Exchange under the ticker symbol PFNX.

ALSO READ: Nine Companies With the Most Unusual Origins

Roka Bioscience Inc. is a molecular diagnostics company primarily developing tests for foodborne pathogens. The company plans to offer 5 million shares in a price range of $14 to $16. Shares are expected to price on Wednesday and begin trading on Thursday on the Nasdaq under the ticker symbol ROKA.

Sage Therapeutics Inc. is a biopharmaceutical firm developing and commercializing novel treatments for central nervous system disorders. The company plans to offer 4 million shares in a price range of $14 to $16. Shares are expected to price on Thursday and begin trading Friday on the Nasdaq under the ticker symbol SAGE.

Trupanion Inc. offers a direct-to-consumer monthly subscription service to provide medical insurance for cats and dogs. The company plans to sell 7.1 million shares in an expected price range of $13 to $15. Shares are set to price on Thursday and begin trading Friday on the NYSE under the ticker symbol TRUP.

TubeMogul Inc. is an enterprise software company for digital branding. The company plans to offer 6.3 million shares in a price range of $11 to $13. The stock will price on Thursday and begin trading Friday on the Nasdaq under the ticker symbol TUBE.

ALSO READ: Ten Cities Where Foreign Companies Create the Most Jobs

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.